SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Glenmark Pharmaceuticals informs about company updates

14 Jan 2020 Evaluate

In furtherance to letter dated May 29, 2019 whereby it had informed the stock exchanges that the Board of Directors of the Company at its meeting held on May 29, 2019 had approved issuance of bonds, whether denominated in Indian Rupee or foreign currency, for an aggregate amount not exceeding USD 200 million in the international market as per applicable law, Glenmark Pharmaceuticals has informed that the Company is contemplating issuance of USD denominated notes for an aggregate amount not exceeding $ 200 million (Notes) subject to market conditions, and the Company’s officials will be participating in roadshow presentations from January 14, 2020 to January 19, 2020 covering Asia, Europe and Middle East. 

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

2360.70 -3.65 (-0.15%)
11-May-2026 11:09 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1882.60
Dr. Reddys Lab 1288.95
Cipla 1341.65
Zydus Lifesciences 943.25
Lupin 2254.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×